Atara Biotherapeutics, Inc. logo

Atara Biotherapeutics, Inc. (ATRA)

Market Closed
17 Jul, 20:00
NASDAQ (NGS) NASDAQ (NGS)
$
8. 39
-0.33
-3.7844%
$
87.94M Market Cap
- P/E Ratio
- Div Yield
81,300 Volume
-2.6 Eps
$ 8.72
Previous Close
Investors:
Analysts:
Add Transaction
Day Range
8.1 8.82
Year Range
3.92 19.14
Want to track ATRA and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Atara Biotherapeutics, Inc. Investors

Name Quantity Cost Value Profit ($) Gain (%)
Point72 Asset Management LP
Point72 Asset Management LP Point72 Asset Management LP
194,264 $1.16M $1.63M $467,542.39 40.19%
PR
Philippe Reitzer Banque Transatlantique SA
176 $2,330 $1,534.72 -$795.28 -34.13%
Kerr Financial Planning Corp
Kerr Financial Planning Corp Kerr Financial Planning Corp
24 $343.92 $209.76 -$134.16 -39.01%